A detailed history of Prudential Financial Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 255,910 shares of DYN stock, worth $6.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
255,910
Previous 253,045 1.13%
Holding current value
$6.13 Million
Previous $8.93 Million 2.95%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$31.94 - $47.04 $91,508 - $134,769
2,865 Added 1.13%
255,910 $9.19 Million
Q2 2024

Aug 13, 2024

BUY
$23.65 - $35.63 $2.55 Million - $3.84 Million
107,885 Added 74.32%
253,045 $8.93 Million
Q1 2024

May 14, 2024

BUY
$13.06 - $29.18 $1.9 Million - $4.24 Million
145,160 New
145,160 $4.12 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.